Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Palladone Side Effects Lawsuits | Side Effects: Fatal Overdosing, Addiction, Deaths

Palladone Side Effects May Lead To Fatal Overdose Lawsuits

Palladone | Lawsuits, Lawyers | Side Effects: Fatal Overdosing, Addiction, Deaths

On July 13, 2005, the Food and Drug Administration ordered Purdue Pharma to remove Palladone (Generic: Hydromorphone hydrochloride from the U.S. market. The FDA cited potentially fatal overdose reactions when the powerful painkiller drug is taken together with alcohol. Palladone is a once-a-day version of the old painkiller Hydromorphone, which uses slow-release delivery to slowly administer this potent narcotic over a 24-hour period. The FDA said the slow-release function can fail, causing the entire dose to enter the bloodstream at once and potentially causing a fatal overdose.

Dr. Steven Galson, FDA Acting Director of the Center for Drug Evaluation and Research said, All powerful pain management drugs have serious risks if used incorrectly, but the current formulation of Palladone presents an unacceptably high level of patient risk. Even one drink could have fatal implications. For this reason the FDA acted quickly, recalling the drug only 5 months after Palladone sales began. The FDA action came after new data gathered from a Purdue Pharma-sponsored study testing the potential effects of alcohol use showed that when Palladone is taken with alcohol the extended release mechanism is harmed, which can lead to dose-dumping. Dose-dumping is a term that describes the rapid release of the active ingredient from an extended release product into the blood stream. The consequences of dose dumping at the lowest marketed dose of Palladone could lead to serious, or even fatal, adverse events in some patients. The risk is even greater for the higher strengths of the product. Purdue Pharma received FDA approval for Palladone in September 2004. Purdue Pharma also manufactures Oxycontin, which has been linked to addiction, overdosing and death.

Legal Help For Victims Affected By Palladone

If you or a loved one took Palladone and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).


PalladoneRSS Feed

Health Canada Follows the FDA in Warning of Potentially Fatal Interaction between Slow-Release Painkillers and Alcohol

Aug 4, 2005 |
Health Canada's Therapeutic Products Directorate (TPD) is the Canadian federal authority that regulates pharmaceutical drugs and medical devices for human use. The agency is the equivalent of the U.S. Food and Drug Administration (FDA). Both have now issued similar warnings concerning the potentially deadly interaction between one particular slow-release “opioid” painkiller, Palladone XL, and alcohol in any amount.The two agencies have taken different approaches to the problem,...

Potentially Fatal Interaction Between Slow-Release Opioid Painkillers And Alcohol

Aug 3, 2005 | Health Canada
Health Canada is advising Canadians of serious health risks when consuming alcohol while taking any type of slow-release painkillers known as opioids. These medications are used for the relief of severe pain over a prolonged period of time.This advisory follows information from Purdue Pharma indicating that its slow-release opioid medication, Palladone XL, may cause serious and potentially fatal problems when taken at the same time with any amount of alcohol. Purdue Pharma has not shipped any...

FDA Asks Purdue Pharma to Withdraw Palladone for Safety Reasons

Jul 13, 2005 |
After acquiring new information that serious and potentially fatal adverse reactions can occur when Palladone (hydromorphone hydrochloride) extended release capsules are taken together with alcohol, the U.S. Food and Drug Administration has asked Purdue Pharma L.P., the makers of the drug, to withdraw it from the market.Palladone is a once-a-day pain management drug containing a very potent narcotic. New data gathered from a company-sponsored study testing the potential effects of alcohol use...

Suspended Marketing of Palladone (Hydromorphone Hydrochloride, Extended Release Capsules)

Jul 13, 2005 |
FDA is issuing this public health advisory to inform patients and health care providers that the sponsor of Palladone, Purdue Pharma, has agreed to suspend sales and marketing of Palladone (hydromorphone hydrochloride, extended release capsules), a potent narcotic painkiller, because of the potential for severe side effects if Palladone is taken with alcohol.Purdue Pharma provided FDA data that showed that drinking alcohol while taking Palladone may cause rapid release of hydromorphone, leading...

Government Orders Halt To Painkiller Sales

Jul 13, 2005 | AP
The Food and Drug Administration ordered a halt to sale of the narcotic Palladone on Wednesday, citing potentially fatal reactions when the potent drug is taken together with alcohol.The FDA approved Palladone just last September. It is a once-a-day version of the old painkiller hydromorphone, made in a way that allows the capsules to dissolve slowly over a 24-hour period.But data from a new study by the drug's manufacturer shows that taking Palladone together with alcohol can harm the...

More Palladone News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo